Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 14, 2020 9:00 AM - Jun 18, 2020 5:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA 2020 Global Annual Meeting

Strategic Directions from Global Medicines Regulators: The ICMRA Statement on Combatting Antimicrobial Resistance

Session Chair(s)

Agnès  Saint-Raymond, DrMed

Agnès Saint-Raymond, DrMed

Head of Division International Affairs

European Medicines Agency, Netherlands

The ICMRA recognizes that antimicrobial resistance (AMR) is a complex, global and multi-faceted problem which poses unique challenges and is committing, in collaboration with WHO, to coordinate regulators efforts around the globe for the fight against AMR.

Learning Objective : Analyze the challenges faced by global regulators for development, commercialization and viability of products that tackle antimicrobial resistance (AMR) and formulate solutions; Recognize the role of the International Coalition of Medicines Regulatory Authorities (ICMRA) in providing strategic directions and coordination to global medicines regulators.

Speaker(s)

Pierre  Sabourin, MBA

Health Canada Update

Pierre Sabourin, MBA

Health Canada, Canada

Assistant Deputy Minister, Health Products and Food Branch

Guido  Rasi, MD

Panelist

Guido Rasi, MD

Tor Vergata University of Rome, Italy

Chairman,Clinical Trial Center of Gemelli Polyclinic Inst; Prof of Microbiology

John  Farley, MD, MPH

Panelist

John Farley, MD, MPH

FDA, United States

Director, Office of Infectious Diseases, OND, CDER

Sini  Eskola, MPharm, MS, MSc

Panelist

Sini Eskola, MPharm, MS, MSc

EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium

Director Regulatory Strategy

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.